Kaya Holdings (KAYS) Non Operating Income (2012 - 2025)
Kaya Holdings (KAYS) recorded quarterly Non Operating Income of -$8.3 million in Q3 2025, down 240.14% quarter-over-quarter from -$2.4 million in Q2 2025, and down 514.23% on a YoY basis from $2.0 million in Q3 2024.
Kaya Holdings (KAYS) Non Operating Income (2012 - 2025) Analysis & Trends
Kaya Holdings' Non Operating Income history runs 14 years deep, the most recent figure standing at -$8.3 million for Q3 2025.
- In Q3 2025, Non Operating Income fell 514.23% year-over-year to -$8.3 million; the TTM figure through Sep 2025 stood at -$12.1 million (down 1499.57% YoY), while the FY2024 annual figure was $3614.0, down 99.86% from the prior year.
- Non Operating Income was -$8.3 million for Q3 2025 at Kaya Holdings, down from -$2.4 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $9.4 million in Q2 2021 to a low of -$8.3 million in Q3 2025.
- Historically, Non Operating Income has averaged -$29406.6 across 5 years, with a median of -$32155.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Non Operating Income soared 1213.67% in 2024, then plunged 37918.76% in 2025.
- A 5-year view of Non Operating Income shows it stood at $3.0 million in 2021, then fell by 14.35% to $2.6 million in 2022, then plunged by 106.32% to -$163831.0 in 2023, then slumped by 727.03% to -$1.4 million in 2024, then slumped by 514.23% to -$8.3 million in 2025.
- The last three Non Operating Income figures came in at -$8.3 million (Q3 2025), -$2.4 million (Q2 2025), and -$1.4 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -23.23 Mn |
| 10 | Kaya Holdings | - | - | 5,370.00 | -8.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -8.32 Mn |
| Jun 30, 2025 | -2.45 Mn |
| Mar 31, 2025 | -1.37 Mn |
| Sep 30, 2024 | -1.35 Mn |
| Jun 30, 2024 | 756,446.00 |
| Mar 31, 2024 | 3,614.00 |
| Dec 31, 2023 | -163,831.00 |
| Sep 30, 2023 | 2.38 Mn |
| Jun 30, 2023 | -67,924.00 |
| Mar 31, 2023 | 377,284.00 |
| Dec 31, 2022 | 2.59 Mn |
| Sep 30, 2022 | -7.14 Mn |
| Jun 30, 2022 | 3.39 Mn |
| Mar 31, 2022 | -768,956.00 |
| Dec 31, 2021 | 3.03 Mn |
| Sep 30, 2021 | 4.41 Mn |
| Jun 30, 2021 | 9.38 Mn |
| Mar 31, 2021 | -5.21 Mn |
| Dec 31, 2020 | 3.73 Mn |
| Sep 30, 2020 | -12.64 Mn |